Bomedemstat (IMG-7289) Plus Ruxolitinib for Myelofibrosis

NCT05569538 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Myelofibrosis

Interventions

DRUG: Bomedemstat

Sponsor

The University of Hong Kong

Collaborators

[object Object]